Comparative Effectiveness of Alternative Strategies for Monitoring Hospital Surgical Performance

监测医院手术表现的替代策略的比较有效性

基本信息

项目摘要

Abstract Important limitations associated with current approaches for monitoring the quality of surgical care include: (a) the retrospective and episodic (e.g.: quarterly, bi-annually, etc.) approach to feedback which creates a time lag between when performance is declining and when the hospital is made aware; (b) small clusters of clinically meaningful poor performance may go of undetected using current episodic analytic structures; (c) most healthcare entities are willing to accept average performance, but will respond if performance starts to fall below an acceptable threshold. As such, alternative approaches that could shorten the time lag for feedback, improve the detection of hospitals with potentially suboptimal perioperative care processes, or inspire hospitals to be more proactive in programmatic improvement could enhance current quality improvement efforts and have tangible benefits for VHA. The overall goal of this proposal is to generate comparative effectiveness data on novel, alternative approaches for monitoring VA hospital surgical performance relative to the current standard of episodic data analysis and feedback. The specific aims are to: (1) compare the CUSUM (a statistical process control methodology borrowed from industry) to the episodic Observed-to-Expected approach for evaluating surgical performance at VA hospitals; (2) evaluate a composite outcome of 30-day mortality, major morbidity, and reoperation as an indicator of declining institutional performance relative to 30-day mortality or overall morbidity alone. This work will involve a hospital-level, observational design using VA Surgical Quality Improvement Program (VASQIP) data for patients who underwent inpatient general, vascular, thoracic, genitourinary, orthopedic, spine, or neurosurgical operations between 2010 and 2016. Data will be used to conduct a comparative effectiveness analysis of these alternative QI strategies for monitoring VA hospital surgical performance relative to the current standard of episodic reporting of 30-day mortality or morbidity individually. This project is novel because it will be the first application of industrial quality control techniques to VASQIP, will provide important real-world comparative data on alternative approaches for evaluating hospital performance, and will evaluate such approaches within the context of the existing VASQIP framework and infrastructure to facilitate future prospective evaluation and eventual implementation. It is anticipated the analyses will demonstrate these alternative approaches could have significant value for hospitals' local quality improvement efforts. Incorporating additional approaches for monitoring surgical outcomes into VASQIP could have notable benefits for VHA and Veterans through earlier recognition of hospitals with potentially problematic perioperative care processes that are associated with suboptimal post- operative outcomes, decreased costs for correcting errant care processes, decreased rates of morbidity through the earlier identification and resolution of such errant processes, and the public perception that the VA remains a national leader in surgical quality. Given the VHA's current focus on ensuring quality care at all levels and in all care settings, it is feasible such alternative approaches could also influence existing quality improvement programs or new initiatives outside of surgery as well.
抽象的 当前监测手术护理质量的方法相关的重要局限性包括: (a) 回顾性和偶发性(例如:每季度、每半年等)反馈方式可以创造时间 绩效下降与医院意识到之间的滞后; (b) 临床小群 使用当前的情景分析结构可能无法检测到有意义的不良表现; (c) 大多数 医疗保健实体愿意接受平均绩效,但如果绩效开始下降,他们会做出反应 低于可接受的阈值。因此,可以缩短反馈时间滞后的替代方法, 改善对围手术期护理流程可能不理想的医院的发现,或启发 医院更加积极主动地进行计划改进可以提高当前的质量改进 努力并为 VHA 带来实实在在的好处。该提案的总体目标是产生比较 监测 VA 医院手术表现的新颖替代方法的有效性数据 情景数据分析和反馈的当前标准。具体目标是:(1)比较CUSUM (从工业界借用的统计过程控制方法)到情景观察到预期 评估 VA 医院手术表现的方法; (2)评估30天的综合结果 死亡率、主要发病率和再手术作为机构绩效相对于 仅 30 天死亡率或总体发病率。这项工作将涉及医院级别的观察性设计,使用 VA 手术质量改进计划 (VASQIP) 数据,适用于接受住院普通科、 2010 年至 2016 年间血管、胸部、泌尿生殖、骨科、脊柱或神经外科手术。数据 将用于对这些监测 VA 的替代 QI 策略进行比较有效性分析 相对于当前 30 天死亡率偶发报告标准的医院手术表现或 单独发病。该项目很新颖,因为它将是工业质量控制的首次应用 VASQIP 技术,将为替代方法提供重要的现实世界比较数据 评估医院绩效,并将在现有 VASQIP 的背景下评估此类方法 促进未来前瞻性评估和最终实施的框架和基础设施。这是 预计分析将证明这些替代方法可能具有重大价值 医院当地的质量改进工作。纳入额外的手术监测方法 通过尽早认识到 VASQIP 的成果可能会给 VHA 和退伍军人带来显着的好处 围手术期护理流程可能存在问题的医院与次优的术后护理流程相关 手术结果、纠正错误护理过程的成本降低、发病率降低 及早识别和解决此类错误流程,以及公众认为 VA 仍然存在 手术质量全国领先。鉴于 VHA 目前的重点是确保各级和各领域的优质护理 在所有护理机构中,此类替代方法也可能影响现有的质量改进,这是可行的 手术之外的计划或新举措也是如此。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Surgical Quality Improvement: Working Toward Value or a Work in Progress?
  • DOI:
    10.1016/j.jss.2018.09.086
  • 发表时间:
    2019-03-01
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Yu, Justin;Massarweh, Nader N.
  • 通讯作者:
    Massarweh, Nader N.
Risk-Adjusted Cumulative Sum for Early Detection of Hospitals With Excess Perioperative Mortality.
用于及早发现围手术期死亡率过高的医院的风险调整累积金额。
  • DOI:
    10.1001/jamasurg.2023.3673
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    16.9
  • 作者:
    Chen,ViviW;Chidi,AlexisP;Dong,Yongquan;Richardson,PeterA;Axelrod,DavidA;Petersen,LauraA;Massarweh,NaderN
  • 通讯作者:
    Massarweh,NaderN
Relationship Between Perioperative Outcomes Used for Profiling Hospital Noncardiac Surgical Quality.
用于分析医院非心脏手术质量的围手术期结果之间的关系。
  • DOI:
    10.1016/j.jss.2021.02.004
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Massarweh,NaderN;Chen,ViviW;Rosen,Tracey;Richardson,PeterA;Harris,AlexHS;Petersen,LauraA
  • 通讯作者:
    Petersen,LauraA
Translating Research Findings Into Practice-The Unfulfilled and Unclear Mission of Observational Data.
将研究成果转化为实践——观测数据未完成且不明确的使命。
  • DOI:
    10.1001/jamasurg.2018.3118
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    16.9
  • 作者:
    Massarweh,NaderN;Chang,GeorgeJ
  • 通讯作者:
    Chang,GeorgeJ
Opportunities to Improve the Capacity to Rescue: Intraoperative and Perioperative Tools.
提高救援能力的机会:术中和围手术期工具。
  • DOI:
    10.1016/j.anclin.2020.08.007
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Klumpner,ThomasT;Massarweh,NaderN;Kheterpal,Sachin
  • 通讯作者:
    Kheterpal,Sachin
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nader Nabile Massarweh其他文献

Examining Care Fragmentation After PAD Interventions: The Readmission Event
  • DOI:
    10.1016/j.jvs.2022.11.019
  • 发表时间:
    2023-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Olamide Alabi;Nader Nabile Massarweh;Xinyan Zheng;Jialin Mao;Yazan Duwayri
  • 通讯作者:
    Yazan Duwayri

Nader Nabile Massarweh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nader Nabile Massarweh', 18)}}的其他基金

Using Modern Data Science Methods and Advanced Analytics to Improve the Efficiency, Reliability, and Timeliness of Cardiac Surgical Quality Data
使用现代数据科学方法和高级分析来提高心脏手术质量数据的效率、可靠性和及时性
  • 批准号:
    10364433
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Using Modern Data Science Methods and Advanced Analytics to Improve the Efficiency, Reliability, and Timeliness of Cardiac Surgical Quality Data
使用现代数据科学方法和高级分析来提高心脏手术质量数据的效率、可靠性和及时性
  • 批准号:
    10542758
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Enhancing the Efficiency of Data Collection for Surgical Quality Improvement
提高数据收集效率以提高手术质量
  • 批准号:
    10641658
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Enhancing the Efficiency of Data Collection for Surgical Quality Improvement
提高数据收集效率以提高手术质量
  • 批准号:
    10334529
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Enhancing the Efficiency of Data Collection for Surgical Quality Improvement
提高数据收集效率以提高手术质量
  • 批准号:
    10187843
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Enhancing the Efficiency of Data Collection for Surgical Quality Improvement
提高数据收集效率以提高手术质量
  • 批准号:
    10547734
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Comparative Effectiveness of Alternative Strategies for Monitoring Hospital Surgical Performance
监测医院手术表现的替代策略的比较有效性
  • 批准号:
    9692259
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Comparative effectiveness of real-time and episodic hospital surgical performance evaluation
实时与间歇式医院手术绩效评估的效果比较
  • 批准号:
    9370221
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
A Population-Based Analysis of Care and Outcomes for Hepatocellular Carcinoma
基于人群的肝细胞癌护理和结果分析
  • 批准号:
    7541665
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
A Population-Based Analysis of Care and Outcomes for Hepatocellular Carcinoma
基于人群的肝细胞癌护理和结果分析
  • 批准号:
    7812042
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了